Bortezomib added to the standard mobilization regimen of G-CSF and high-dose cyclophosphamide is a safe and effective combination for a high yield stem cell collection while promoting further tumor mass reduction in myeloma.

被引：3

作者：

Stern, Jessica L. ^{[1
]}

Di Carlo, Brian ^{[1
]}

Schuster, Michael W. ^{[1
]}

Shore, Tsiporah B. ^{[1
]}

Harpel, John G. ^{[1
]}

Pearse, Roger ^{[1
]}

Zafar, Faiza ^{[1
]}

Dymek, Joanne ^{[1
]}

Ryan, Jessy ^{[1
]}

Jayabalan, David ^{[1
]}

Chen-Kiang, Selina ^{[1
]}

Ely, Scott ^{[1
]}

Leonard, John P. ^{[1
]}

Coleman, Morton ^{[1
]}

Niesvizky, Ruben ^{[1
]}

机构：

[1] Presbyterian Hosp, Weill Cornell Med Coll, Ctr Excellence Lymphoma & Myeloma, New York, NY USA

来源：

BLOOD | 2006年 / 108卷 / 11期

关键词：

D O I：

10.1182/blood.V108.11.2953.2953

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2953

引用

页码：837A / 837A

页数：1

共 45 条

[1] Combination high-dose cyclophosphamide and bortezomib is safe and effective for stem cell harvesting in chemotherapy refractory multiple myeloma.
Katzman, Miriam
George, Theresa
Doell, Heather
Danyluk, Patricia
Briggs, Sheri
Hasegawa, Wanda
Fibich, Christian
Voralia, Michael
BLOOD, 2006, 108 (11) : 460B - 460B
[2] DCEP(Dexamethasone, cyclophosphamide, etoposide, cisplatin) followed by high-dose G-CSF is a highly efficient and safe regimen for stem cell mobilization for multiple myeloma
Gonsky, Jason P.
Lendvai, Nikoletta
Donato, Michele L.
Rowley, Scott D.
Pecora, Andrew L.
Feldman, Tatyana
Goy, Andre
Goldberg, Stuart
Siegel, David S.
BLOOD, 2007, 110 (11) : 965A - 965A
[3] SAFE AND EFFECTIVE MOBILIZATION OF STEM CELLS IN MULTIPLE MYELOMA FOLLOWING PRIMING BY HIGH-DOSE CYCLOPHOSPHAMIDE AND BORTEZOMIB
Mikala, G.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 263 - 263
[4] BORTEZOMIB ADDED TO HIGH-DOSE CYCLOPHOSPHAMIDE DURING STEM CELL MOBILIZATION IS SAFE AND PROVIDES EFFECTIVE DISEASE CONTROL IN CHEMOTHERAPY-REFRACTORY MULTIPLE MYELOMA
Voralia, M.
Fibich, C.
Katzman, M.
Danyluk, P.
George, T.
Doell, H.
Evjen, A.
vanden Berghe, J.
Briggs, S.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 68 - 69
[5] RESPONSE TO INDUCTION TREATMENT ADAPTED SELECTION OF MOBILIZATION REGIMEN IN MULTIPLE MYELOMA: THE G-CSF ALONE VERSUS HIGH-DOSE CYCLOPHOSPHAMIDE PLUS G-CSF REGIMEN
Lee, J. Y.
Kim, S. J.
Jang, J. E.
Suh, C.
Lee, H.
Yhim, H. Y.
Lee, W. S.
Min, C. K.
Lee, J. H.
Kim, J. S.
HAEMATOLOGICA, 2014, 99 : 647 - 648
[6] RESPONSE TO INDUCTION TREATMENT ADAPTED SELECTION OF MOBILIZATION REGIMEN IN MULTIPLE MYELOMA: THE G-CSF ALONE VERSUS HIGH-DOSE CYCLOPHOSPHAMIDE PLUS G-CSF REGIMEN
Jungyeon, L.
Jeong, K. Soo
Eun, J. Ji
Chelwon, S.
Hyewon, L.
Ho-Young, Y.
Sik, L. Won
Chang-Ki, M.
Hoon, L. Jae
Seok, K. Jin
BONE MARROW TRANSPLANTATION, 2014, 49 : S525 - S526
[7] Peripheral blood stem cell mobilization in multiple myeloma (MM): High-dose cyclophosphamide plus G-CSF vs. G-CSF alone
Goldschmidt, H
Hegenbart, U
Cremer, FW
Kiel, K
Moos, M
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 72 - 72
[8] DCEP (dexamethasone, cyclophosphamide, etoposide and cisplatin) plus G-CSF is an effective regimen for peripheral stem cell collection in multiple myeloma.
Lazzarino, M
Corso, A
Barbarano, L
Alessandrino, EP
Fava, S
Ferrari, D
Fiumanò, M
Frigerio, G
Isa, L
Luraschi, A
Montanara, S
Nosari, A
Perego, D
Pinotti, G
Rodeghiero, F
Santagostino, A
Savarè, M
Ucci, G
Uziel, L
Vismara, A
Morra, E
BLOOD, 2000, 96 (11) : 757A - 757A
[9] COMPARISON OF HIGH-DOSE CYCLOPHOSPHAMIDE PLUS G-CSF WITH G-CSF ALONE FOR PERIPHERAL BLOOD STEM CELL MOBILIZATION IN MM
Jang, J. E.
Hyun, S. Y.
Hwang, D. Y.
Yoon, S. H.
Kim, Y. D.
Kim, S. J.
Kim, J. S.
Cheong, J. -W.
Min, Y. H.
ANNALS OF ONCOLOGY, 2012, 23 : 83 - 83
[10] High-Dose Cyclophosphamide In Combination With G-CSF Versus G-CSF Alone For Mobilization Of Hematopoietic Stem Cells After Induction Therapy Including Velcade, Cyclophosphamide and Dexacort
Benyamini, Noam
Avivi, Irit
Dann, Eldad J.
Zuckerman, Tsila
Noa, Lavi
Katz, Tami
BLOOD, 2013, 122 (21)

← 1 2 3 4 5 →